The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Bioinformatics Global Market Report 2024, the bioinformatics market is expected to show significant growth in the forecast period.

The bioinformatics market has experienced significant expansion in recent years, with the market size reaching $14.86 billion in 2023. A compound annual growth rate (CAGR) of 13.7% is projected, driving the market to $16.9 billion in 2024. This growth is attributed to various factors in the historic period, including advancements in genomic sequencing, biomedical research expansion, drug discovery and development, personalized medicine, and applications in agriculture and biotechnology.

Charting the Future: Projected Growth and Trends
Looking ahead, the bioinformatics market is poised for rapid expansion, anticipating a surge to $28.27 billion in 2028 at the same CAGR of 13.7%. This growth in the forecast period is fueled by advancements in omics technologies, artificial intelligence (AI) and machine learning, data integration and cloud computing, biomarker discovery, and diagnostics. Major trends in the upcoming years include the explosion of genomic data, personalized medicine, the integration of machine learning and AI, and continued progress in drug discovery and development.

Protein Sequencing: A Key Driver of Bioinformatics Market Growth
Understanding Protein Sequencing
The escalating demand for protein sequencing is a pivotal factor propelling the bioinformatics market forward. Protein sequencing involves determining the sequence of amino acids in proteins, aiding in the understanding of their functions, activities, origin, and localization. Bioinformatics methods and databases play a crucial role in identifying the capacity, structure, and developmental history of proteins.

Factors Driving Protein Sequencing Demand
The demand for protein sequencing is set to increase due to advancements in clinical mass spectrometry and analytical techniques. Moreover, the widespread adoption of target-based drug development by pharmaceutical and biotechnology companies further contributes to this trend. In 2021 alone, the total number of protein sequences in UniProtKB reached approximately 190 million.

View More On The Bioinformatics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/bioinformatics-global-market-report

Investments in Nanopore Sequencing: A Technological Leap Forward
Nanopore Sequencing Technology
Companies in the bioinformatics market are channeling their investments into the research and development of nanopore sequencing technology. This revolutionary single-molecule DNA sequencing technique eliminates the need for Polymerase Chain Reaction or chemical labeling, offering high throughput, low cost, and longer reads.

Industry Boost: Oxford Nanopore Technologies
In 2021, Oxford Nanopore Technologies secured $705.56 million in an IPO to support commercial and manufacturing operations and further develop its nanopore technology. This technology’s ability to measure changes in ionic current as biological molecules pass through nanopores is a game-changer, aiding in data collection crucial for bioinformatics analysis.

Strategic Acquisitions: ZS Associates and Intomics A/S
ZS Associates’ Move into Bioinformatics
In May 2022, ZS Associates, a US-based management consulting and technology firm, acquired Intomics A/S, a Denmark-based bioinformatics and systems biology company. This strategic move aims to enhance ZS Associates’ drug discovery and bioinformatics capabilities, aligning with their goal to accelerate drug discovery and improve success rates in drug development.

Segmentation of the Bioinformatics Market
Understanding Market Dynamics
The bioinformatics market is segmented based on products and services, applications, and end-users:

1. Products and Services:
   • Knowledge Management Tools
   • Data Analysis Platforms
   • Services
2. Applications:
   • Metabolomics
   • Molecular Phylogenetics
   • Transcriptomics
   • Proteomics
   • Chemoinformatics
   • Genomics
   • Other Applications
3. End Users:
   • Pharmaceutics
   • Animal Study
   • Agriculture
   • Forensic Science
   • Other End Users

Regional Dominance: North America Leads
In 2023, North America emerged as the largest region in the bioinformatics market, showcasing the region’s prominence in driving advancements and innovations in this field.

In Conclusion
As the bioinformatics market continues its upward trajectory, fueled by technological advancements, strategic acquisitions, and a robust demand for protein sequencing, the industry is set to play a pivotal role in shaping the future of genomics, drug discovery, and personalized medicine. Investors, researchers, and stakeholders alike should closely monitor the dynamic landscape of this market for emerging opportunities and trends.

Request A Sample Of The Global Bioinformatics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=2483&type=smp